ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELOFIBROSIS - CLOSE POST-TRANSPLANT SURVEILLANCE IS MANDATORY

被引：0

作者：

Baurmann, H. ^{[1
]}

Thiede, C. ^{[2
]}

Burlakova, I ^{[1
]}

Judith, D. ^{[1
]}

Heshmat, M. ^{[1
]}

Schleuning, M. ^{[1
]}

Schwerdtfeger, R. ^{[1
]}

机构：

[1] German Clin Diagnost, Wiesbaden, Germany

[2] Univ Hosp Carl Gustav Carus, Dresden, Germany

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期

关键词：

D O I：

10.1016/j.bbmt.2009.12.398

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

354

引用

页码：S289 / S289

页数：1

共 50 条

[31] Nutritional Status of Allogeneic Hematopoietic Stem Cell Transplant Recipients and Post-transplant Outcomes [J].

Szovati, Stephanie ;

Morrison, Caroline F. ;

Couch, Sarah C. .

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2023, 75 (04) :1200-1210

[32] Evaluation of Post-Transplant Iron Chelation Therapy in Allogeneic Hematopoietic Stem Cell Transplant [J].

Aziz, May ;

Gregory, Kelly ;

Corrigan, Patricia .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) :S376-S376

[33] T-cell post-transplant lymphoproliferative disorder in a patient with chronic idiopathic myelofibrosis following allogeneic PBSC transplantation [J].

A Nishida ;

H Yamamoto ;

Y Ohta ;

M Karasawa ;

D Kato ;

N Uchida ;

A Wake ;

S Taniguchi .

Bone Marrow Transplantation, 2010, 45 :1372-1374

[34] T-cell post-transplant lymphoproliferative disorder in a patient with chronic idiopathic myelofibrosis following allogeneic PBSC transplantation [J].

Nishida, A. ;

Yamamoto, H. ;

Ohta, Y. ;

Karasawa, M. ;

Kato, D. ;

Uchida, N. ;

Wake, A. ;

Taniguchi, S. .

BONE MARROW TRANSPLANTATION, 2010, 45 (08) :1372-1374

[35] Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes [J].

Bannow, Bethany T. Samuelson ;

Salit, Rachel B. ;

Storer, Barry E. ;

Stevens, Emily A. ;

Wu, David ;

Yeung, Cecilia ;

Fang, Min ;

Petersdorf, Effie W. ;

Linenberger, Michael L. ;

Woo, Janghee ;

Sorror, Mohamed L. ;

Doney, Kris ;

Sandmaier, Brenda M. ;

Deeg, H. Joachim ;

Scott, Bart L. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (02) :386-392

[36] Allogeneic hematopoietic stem-cell transplantation for myelofibrosis [J].

Zhang, Lining ;

Yang, Fan ;

Feng, Sizhou .

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11

[37] Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation [J].

Frank Lieberman ;

Victor Yazbeck ;

Anastasios Raptis ;

Raymond Felgar ;

Michael Boyiadzis .

Journal of Neuro-Oncology, 2012, 107 :225-232

[38] Post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation: A single-center experience [J].

Luo, Lan ;

Zhang, Lin ;

Cai, Bo ;

Li, Honghua ;

Huang, Wenrong ;

Jing, Yu ;

Zhu, Haiyan ;

Zhao, Yu ;

Bo, Jian ;

Wang, Quanshun ;

Han, Xiaoping ;

Yu, Li ;

Gao, Chunji .

ANNALS OF TRANSPLANTATION, 2014, 19 :6-12

[39] Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation [J].

Nakamae, Hirohisa .

FRONTIERS IN IMMUNOLOGY, 2024, 15

[40] Haploidentical Hematopoietic Stem Cell Transplantation with post-transplant Cyclophosphamide for Osteopetrosis [J].

Even-Or, Ehud ;

Zaidman, Irina ;

Stepensky, Polina .

BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) :391-391

← 1 2 3 4 5 →